| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.082 | 0.1 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.086 | 0.1 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |